Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos

Return to: PBR Home | Packaging

Regeneca recalls specific lot of RegenArouse

PBR Staff Writer Published 13 February 2012

Regeneca has issued a voluntary nationwide recall of RegenArouse, lot number 130100, as it contains a drug not listed on the label.

Tadalafil is an FDA-approved drug used as treatment for male erectile dysfunction (ED).

The active drug ingredient is not listed on the label for these products.

Tadafil could interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.

RegenArouse, lot number 130100, is a pink capsule sold individually in foil packets, with the expiration date of 12/5/2013 and a UPC code of 816860010079.